Kentucky Retirement Systems Insurance Trust Fund acquired a new position in shares of Xylem Inc (NYSE:XYL) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 3,555 shares of the industrial products company’s stock, valued at approximately $237,000.
Other hedge funds and other institutional investors have also modified their holdings of the company. Impax Asset Management Group plc lifted its position in Xylem by 18.3% in the 4th quarter. Impax Asset Management Group plc now owns 4,299,123 shares of the industrial products company’s stock worth $286,837,000 after buying an additional 666,437 shares during the last quarter. Amundi Pioneer Asset Management Inc. lifted its position in Xylem by 61.3% in the 4th quarter. Amundi Pioneer Asset Management Inc. now owns 1,662,661 shares of the industrial products company’s stock worth $110,933,000 after buying an additional 631,858 shares during the last quarter. Ceredex Value Advisors LLC bought a new stake in Xylem in the 4th quarter worth approximately $39,742,000. Ardevora Asset Management LLP bought a new stake in Xylem in the 4th quarter worth approximately $35,408,000. Finally, Prio Wealth Limited Partnership bought a new stake in Xylem in the 4th quarter worth approximately $20,852,000. 87.11% of the stock is owned by institutional investors.
Shares of XYL stock opened at $80.56 on Tuesday. The company has a quick ratio of 1.08, a current ratio of 1.51 and a debt-to-equity ratio of 0.74. Xylem Inc has a fifty-two week low of $60.65 and a fifty-two week high of $82.44. The company has a market capitalization of $14.19 billion, a price-to-earnings ratio of 27.97, a P/E/G ratio of 1.36 and a beta of 1.14.
The business also recently disclosed a quarterly dividend, which was paid on Thursday, March 14th. Shareholders of record on Thursday, February 14th were given a $0.24 dividend. The ex-dividend date of this dividend was Wednesday, February 13th. This represents a $0.96 annualized dividend and a yield of 1.19%. This is an increase from Xylem’s previous quarterly dividend of $0.21. Xylem’s payout ratio is presently 33.33%.
In other Xylem news, insider Tomas Brannemo sold 559 shares of the business’s stock in a transaction that occurred on Thursday, February 21st. The stock was sold at an average price of $74.44, for a total value of $41,611.96. Following the completion of the sale, the insider now owns 10,568 shares in the company, valued at $786,681.92. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Steven R. Loranger sold 10,000 shares of the business’s stock in a transaction that occurred on Friday, March 15th. The shares were sold at an average price of $76.99, for a total value of $769,900.00. Following the transaction, the director now directly owns 26,744 shares in the company, valued at $2,059,020.56. The disclosure for this sale can be found here. Insiders sold 56,921 shares of company stock valued at $4,128,457 in the last quarter. Corporate insiders own 0.81% of the company’s stock.
A number of analysts recently weighed in on XYL shares. Stifel Nicolaus upgraded Xylem from a “hold” rating to a “buy” rating and boosted their target price for the stock from $72.00 to $75.00 in a research report on Wednesday, December 19th. BMO Capital Markets restated a “buy” rating and issued a $85.00 target price on shares of Xylem in a research report on Monday, February 25th. ValuEngine downgraded Xylem from a “buy” rating to a “hold” rating in a research report on Monday, February 4th. Zacks Investment Research upgraded Xylem from a “sell” rating to a “hold” rating in a research report on Saturday, January 26th. Finally, Oppenheimer set a $80.00 target price on Xylem and gave the stock a “buy” rating in a research report on Monday, February 4th. One research analyst has rated the stock with a sell rating, six have assigned a hold rating and nine have assigned a buy rating to the company’s stock. The stock has an average rating of “Buy” and a consensus price target of $78.36.
COPYRIGHT VIOLATION NOTICE: “Kentucky Retirement Systems Insurance Trust Fund Takes $237,000 Position in Xylem Inc (XYL)” was originally reported by Sports Perspectives and is the property of of Sports Perspectives. If you are viewing this article on another publication, it was copied illegally and republished in violation of U.S. and international copyright and trademark legislation. The legal version of this article can be viewed at https://sportsperspectives.com/2019/04/02/kentucky-retirement-systems-insurance-trust-fund-takes-237000-position-in-xylem-inc-xyl.html.
Xylem Inc engages in the design, manufacture, and servicing of engineered products and solutions for the water and wastewater applications. It operates in three segments: Water Infrastructure, Applied Water, and Measurement & Control Solutions. The Water Infrastructure segment offers various products, including water and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment under the Flygt, Godwin, Wedeco, Sanitaire, and Leopold names for the transportation and treatment of water.
Further Reading: Asset Allocation
Want to see what other hedge funds are holding XYL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Xylem Inc (NYSE:XYL).
Receive News & Ratings for Xylem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem and related companies with MarketBeat.com's FREE daily email newsletter.